menu search

Opendoor: low-margin, asset-intensive businesses can succeed

Opendoor: Low-Margin, Asset-intensive Businesses Can Succeed...

February 10, 2022, 2:49 am

Opendoor: low-margin, asset-intensive businesses can succeed

Opendoor: Low-Margin, Asset-intensive Businesses Can Succeed...

February 10, 2022, 2:49 am

Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results

WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...

February 2, 2022, 6:45 am

Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results

WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...

February 2, 2022, 6:45 am

Descartes sets date to announce fiscal 2022 fourth quarter and year-end financial results

WATERLOO, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-...

February 2, 2022, 6:45 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Apollon formularies names dr archibald mcdonald as clinical trials director

Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...

January 21, 2022, 7:57 am

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite

WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...

October 6, 2021, 6:45 am

Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite

WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...

October 6, 2021, 6:45 am

Descartes unveils artificial intelligence and machine learning enhancements to routing, mobile & telematics suite

WATERLOO, Ontario, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-...

October 6, 2021, 6:45 am


Search within

Pages Search Results: